704 related articles for article (PubMed ID: 22864622)
1. Aurora A kinase (AURKA) in normal and pathological cell division.
Nikonova AS; Astsaturov I; Serebriiskii IG; Dunbrack RL; Golemis EA
Cell Mol Life Sci; 2013 Feb; 70(4):661-87. PubMed ID: 22864622
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
3. Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle.
Stenoien DL; Sen S; Mancini MA; Brinkley BR
Cell Motil Cytoskeleton; 2003 Jun; 55(2):134-46. PubMed ID: 12740874
[TBL] [Abstract][Full Text] [Related]
4. The Aurora kinase family in cell division and cancer.
Vader G; Lens SM
Biochim Biophys Acta; 2008 Sep; 1786(1):60-72. PubMed ID: 18662747
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis.
Plotnikova OV; Nikonova AS; Loskutov YV; Kozyulina PY; Pugacheva EN; Golemis EA
Mol Biol Cell; 2012 Jul; 23(14):2658-70. PubMed ID: 22621899
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of Aurora kinase inhibitors in cancer.
Naruganahalli KS; Lakshmanan M; Dastidar SG; Ray A
Curr Opin Investig Drugs; 2006 Dec; 7(12):1044-51. PubMed ID: 17209521
[TBL] [Abstract][Full Text] [Related]
7. Targeting Aurora-2 kinase in cancer.
Warner SL; Bearss DJ; Han H; Von Hoff DD
Mol Cancer Ther; 2003 Jun; 2(6):589-95. PubMed ID: 12813139
[TBL] [Abstract][Full Text] [Related]
8. Aurora kinase inhibitors--rising stars in cancer therapeutics?
Dar AA; Goff LW; Majid S; Berlin J; El-Rifai W
Mol Cancer Ther; 2010 Feb; 9(2):268-78. PubMed ID: 20124450
[TBL] [Abstract][Full Text] [Related]
9. Targeting aurora kinases in cancer treatment.
Kelly KR; Ecsedy J; Mahalingam D; Nawrocki ST; Padmanabhan S; Giles FJ; Carew JS
Curr Drug Targets; 2011 Dec; 12(14):2067-78. PubMed ID: 21777198
[TBL] [Abstract][Full Text] [Related]
10. The Aurora kinases: role in cell transformation and tumorigenesis.
Katayama H; Brinkley WR; Sen S
Cancer Metastasis Rev; 2003 Dec; 22(4):451-64. PubMed ID: 12884918
[TBL] [Abstract][Full Text] [Related]
11. The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis.
Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
Cell Cycle; 2009 Aug; 8(15):2385-98. PubMed ID: 19556893
[TBL] [Abstract][Full Text] [Related]
12. Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.
Hegyi K; Méhes G
Pathol Oncol Res; 2012 Oct; 18(4):761-9. PubMed ID: 22843098
[TBL] [Abstract][Full Text] [Related]
13. Aurora kinase inhibitors as anticancer molecules.
Katayama H; Sen S
Biochim Biophys Acta; 2010; 1799(10-12):829-39. PubMed ID: 20863917
[TBL] [Abstract][Full Text] [Related]
14. Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules.
Wu JM; Chen CT; Coumar MS; Lin WH; Chen ZJ; Hsu JT; Peng YH; Shiao HY; Lin WH; Chu CY; Wu JS; Lin CT; Chen CP; Hsueh CC; Chang KY; Kao LP; Huang CY; Chao YS; Wu SY; Hsieh HP; Chi YH
Proc Natl Acad Sci U S A; 2013 May; 110(19):E1779-87. PubMed ID: 23610398
[TBL] [Abstract][Full Text] [Related]
15. [The function of Aurora A and its role in the development of liver cancer].
Li M; Ren ZG
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):477-480. PubMed ID: 28763871
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
18. An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor.
Durlacher CT; Li ZL; Chen XW; He ZX; Zhou SF
Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):585-601. PubMed ID: 26999067
[TBL] [Abstract][Full Text] [Related]
19. Cdk1 activity is required for mitotic activation of aurora A during G2/M transition of human cells.
Van Horn RD; Chu S; Fan L; Yin T; Du J; Beckmann R; Mader M; Zhu G; Toth J; Blanchard K; Ye XS
J Biol Chem; 2010 Jul; 285(28):21849-57. PubMed ID: 20444701
[TBL] [Abstract][Full Text] [Related]
20. Aurora-B kinase inhibitors for cancer chemotherapy.
Yeung SC; Gully C; Lee MH
Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
